[{"id":"e5a1e1ed-835e-42f6-b648-d803c13e2542","acronym":"","url":"https://clinicaltrials.gov/study/NCT01774071","created_at":"2021-01-18T07:49:16.883Z","updated_at":"2024-07-02T16:35:49.015Z","phase":"Phase 1/2","brief_title":"Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer","source_id_and_acronym":"NCT01774071","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" STEAP1","pipe":"","alterations":" ","tags":["STEAP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e vandortuzumab vedotin (RG7450)"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 01/01/2013","start_date":" 01/01/2013","primary_txt":" Primary completion: 05/02/2023","primary_completion_date":" 05/02/2023","study_txt":" Completion: 05/02/2023","study_completion_date":" 05/02/2023","last_update_posted":"2023-05-04"}]